Search research articles
Contact Us
Filters
Showing results (41-50 of 70) with videos related to
Page
of 7
Sort By:
Anticancer Research
|
March 1, 1997
Human epithelial ovarian cancer xenotransplants into nude mice can be cured by adenovirus-mediated thymidine kinase gene therapy
X W Tong, I Agoulnik, K Blankenburg, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 14, 2005
The role of surgery in recurrent ovarian cancer
J Pfisterer, P Harter, U Canzler, et al.
British Journal of Cancer
|
October 29, 2009
Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes
M Stumpf, A Hasenburg, M-O Riener, et al.
Cancer Gene Therapy
|
July 6, 2000
Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer
A Hasenburg, X W Tong, A Rojas-Martinez, et al.
Journal of Cancer Research and Clinical Oncology
|
March 3, 2017
Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer
Anne-Sophie Heimes, K Madjar, K Edlund, et al.
Breast Cancer Research and Treatment
|
June 7, 2017
Subtype-specific prognostic impact of different immune signatures in node-negative breast cancer
A-S Heimes, K Madjar, K Edlund, et al.
Journal of the Society for Gynecologic Investigation
|
May 16, 2002
Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: expression of coxsackie-adenovirus receptor and integrins alphavbeta3 and alphavbeta5
A Hasenburg, D-C Fischer, X-W Tong, et al.
Breast Cancer Research and Treatment
|
May 22, 2020
EndoPredict<sup>®</sup> in early hormone receptor-positive, HER2-negative breast cancer
K Almstedt, S Mendoza, M Otto, et al.
Breast Cancer Research and Treatment
|
June 5, 2020
Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer-results of an exploratory case-control study
S Krajnak, C Schnatz, K Almstedt, et al.
Anticancer Research
|
September 3, 1999
Thymidine kinase (TK) gene therapy of solid tumors: valacyclovir facilitates outpatient treatment
A Hasenburg, X W Tong, A Rojas-Martinez, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 70) with videos related to
Sort By:
Page
of 7
Anticancer Research
|
March 1, 1997
Human epithelial ovarian cancer xenotransplants into nude mice can be cured by adenovirus-mediated thymidine kinase gene therapy
X W Tong, I Agoulnik, K Blankenburg, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 14, 2005
The role of surgery in recurrent ovarian cancer
J Pfisterer, P Harter, U Canzler, et al.
British Journal of Cancer
|
October 29, 2009
Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes
M Stumpf, A Hasenburg, M-O Riener, et al.
Cancer Gene Therapy
|
July 6, 2000
Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer
A Hasenburg, X W Tong, A Rojas-Martinez, et al.
Journal of Cancer Research and Clinical Oncology
|
March 3, 2017
Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer
Anne-Sophie Heimes, K Madjar, K Edlund, et al.
Breast Cancer Research and Treatment
|
June 7, 2017
Subtype-specific prognostic impact of different immune signatures in node-negative breast cancer
A-S Heimes, K Madjar, K Edlund, et al.
Journal of the Society for Gynecologic Investigation
|
May 16, 2002
Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: expression of coxsackie-adenovirus receptor and integrins alphavbeta3 and alphavbeta5
A Hasenburg, D-C Fischer, X-W Tong, et al.
Breast Cancer Research and Treatment
|
May 22, 2020
EndoPredict<sup>®</sup> in early hormone receptor-positive, HER2-negative breast cancer
K Almstedt, S Mendoza, M Otto, et al.
Breast Cancer Research and Treatment
|
June 5, 2020
Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer-results of an exploratory case-control study
S Krajnak, C Schnatz, K Almstedt, et al.
Anticancer Research
|
September 3, 1999
Thymidine kinase (TK) gene therapy of solid tumors: valacyclovir facilitates outpatient treatment
A Hasenburg, X W Tong, A Rojas-Martinez, et al.
Page
of 7